{"id":2646,"date":"2020-02-07T18:12:15","date_gmt":"2020-02-07T17:12:15","guid":{"rendered":"https:\/\/www.rcts.fr\/uncategorized\/utilisation-quotidienne-du-facteur-vii-active-recombinant-dans-les-saignements-aigus-de-lhemophile-acquise-a-resultats-dacqui-7-une-etude-francaise-prospective"},"modified":"2020-04-07T15:58:09","modified_gmt":"2020-04-07T13:58:09","slug":"utilisation-quotidienne-du-facteur-vii-active-recombinant-dans-les-saignements-aigus-de-lhemophile-acquise-a-resultats-dacqui-7-une-etude-francaise-prospective","status":"publish","type":"post","link":"https:\/\/www.rcts.fr\/en\/utilisation-quotidienne-du-facteur-vii-active-recombinant-dans-les-saignements-aigus-de-lhemophile-acquise-a-resultats-dacqui-7-une-etude-francaise-prospective\/","title":{"rendered":"Utilisation quotidienne du facteur VII activ\u00e9 recombinant dans les saignements aigus de l\u2019h\u00e9mophile acquise A : r\u00e9sultats d\u2019ACQUI-7, une \u00e9tude fran\u00e7aise prospective"},"content":{"rendered":"<p><span>L\u2019efficacit\u00e9 et la tol\u00e9rance du facteur VII activ\u00e9 recombinant (rFVIIa) sont reconnues chez les patients avec une h\u00e9mophilie A acquise (HAA), mais des donn\u00e9es d\u00e9taill\u00e9es sur le contr\u00f4le du saignement en pratique m\u00e9dicale sont limit\u00e9es.<\/span><\/p>\n<p id=\"spar0010\">L\u2019objectif de cette \u00e9tude prospective, observationnelle, multicentrique, fran\u00e7aise (ACQUI-7) \u00e9tait de renforcer les connaissances sur les diff\u00e9rents types de saignements survenant chez des patients HAA (titre de l\u2019auto-anticorps anti-FVIII\u00a0&gt;\u00a01\u00a0UB\u00a0; taux de FVIII\u00a0&lt;\u00a050\u00a0%) et d\u00e9tailler l\u2019utilisation quotidienne du rFVIIa en conditions r\u00e9elles.<\/p>\n<p id=\"spar0015\">Les donn\u00e9es ont \u00e9t\u00e9 collect\u00e9es dans 20\u00a0centres de traitement de l\u2019h\u00e9mophilie ou d\u00e9partement de m\u00e9decine interne entre 2010\u00a0et 2013. Apr\u00e8s inclusion pour prise en charge d\u2019un \u00e9pisode h\u00e9morragique trait\u00e9 par rFVIIa en 1<sup>re<\/sup><span>\u00a0<\/span>ou 2<sup>nde<\/sup><span>\u00a0<\/span>intention, les patients \u00e9taient suivis pendant 1\u00a0an. Les modalit\u00e9s d\u2019utilisation du rFVIIa \u00e9taient laiss\u00e9es au libre arbitre de l\u2019investigateur.<\/p>\n<p>&nbsp;<\/p>\n<p><a href=\"https:\/\/doi.org\/10.1016\/j.revmed.2016.10.236\" rel=\"noopener noreferrer\" target=\"_blank\">Dec 2016 &#8211; La Revue de M\u00e9decine Interne<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>L\u2019efficacit\u00e9 et la tol\u00e9rance du facteur VII activ\u00e9 recombinant (rFVIIa) sont reconnues chez les patients avec une h\u00e9mophilie A acquise (HAA), mais des donn\u00e9es d\u00e9taill\u00e9es sur le contr\u00f4le du saignement en pratique m\u00e9dicale sont limit\u00e9es. L\u2019objectif de cette \u00e9tude prospective, observationnelle, multicentrique, fran\u00e7aise (ACQUI-7) \u00e9tait de renforcer les connaissances sur les diff\u00e9rents types de saignements [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false},"categories":[60],"class_list":["post-2646","post","type-post","status-publish","format-standard","hentry","category-haematology"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Utilisation quotidienne du facteur VII activ\u00e9 recombinant dans les saignements aigus de l\u2019h\u00e9mophile acquise A : r\u00e9sultats d\u2019ACQUI-7, une \u00e9tude fran\u00e7aise prospective - RCTs<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"http:\/\/www.rcts.fr\/en\/utilisation-quotidienne-du-facteur-vii-active-recombinant-dans-les-saignements-aigus-de-lhemophile-acquise-a-resultats-dacqui-7-une-etude-francaise-prospective\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Utilisation quotidienne du facteur VII activ\u00e9 recombinant dans les saignements aigus de l\u2019h\u00e9mophile acquise A : r\u00e9sultats d\u2019ACQUI-7, une \u00e9tude fran\u00e7aise prospective - RCTs\" \/>\n<meta property=\"og:description\" content=\"L\u2019efficacit\u00e9 et la tol\u00e9rance du facteur VII activ\u00e9 recombinant (rFVIIa) sont reconnues chez les patients avec une h\u00e9mophilie A acquise (HAA), mais des donn\u00e9es d\u00e9taill\u00e9es sur le contr\u00f4le du saignement en pratique m\u00e9dicale sont limit\u00e9es. L\u2019objectif de cette \u00e9tude prospective, observationnelle, multicentrique, fran\u00e7aise (ACQUI-7) \u00e9tait de renforcer les connaissances sur les diff\u00e9rents types de saignements [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"http:\/\/www.rcts.fr\/en\/utilisation-quotidienne-du-facteur-vii-active-recombinant-dans-les-saignements-aigus-de-lhemophile-acquise-a-resultats-dacqui-7-une-etude-francaise-prospective\/\" \/>\n<meta property=\"og:site_name\" content=\"RCTs\" \/>\n<meta property=\"article:published_time\" content=\"2020-02-07T17:12:15+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2020-04-07T13:58:09+00:00\" \/>\n<meta name=\"author\" content=\"Didier Not\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Didier Not\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"http:\\\/\\\/www.rcts.fr\\\/en\\\/utilisation-quotidienne-du-facteur-vii-active-recombinant-dans-les-saignements-aigus-de-lhemophile-acquise-a-resultats-dacqui-7-une-etude-francaise-prospective\\\/#article\",\"isPartOf\":{\"@id\":\"http:\\\/\\\/www.rcts.fr\\\/en\\\/utilisation-quotidienne-du-facteur-vii-active-recombinant-dans-les-saignements-aigus-de-lhemophile-acquise-a-resultats-dacqui-7-une-etude-francaise-prospective\\\/\"},\"author\":{\"name\":\"Didier Not\",\"@id\":\"http:\\\/\\\/www.rcts.fr\\\/#\\\/schema\\\/person\\\/19ff6b0ca72b83f30ac0a23e6ce05dc5\"},\"headline\":\"Utilisation quotidienne du facteur VII activ\u00e9 recombinant dans les saignements aigus de l\u2019h\u00e9mophile acquise A : r\u00e9sultats d\u2019ACQUI-7, une \u00e9tude fran\u00e7aise prospective\",\"datePublished\":\"2020-02-07T17:12:15+00:00\",\"dateModified\":\"2020-04-07T13:58:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"http:\\\/\\\/www.rcts.fr\\\/en\\\/utilisation-quotidienne-du-facteur-vii-active-recombinant-dans-les-saignements-aigus-de-lhemophile-acquise-a-resultats-dacqui-7-une-etude-francaise-prospective\\\/\"},\"wordCount\":196,\"commentCount\":0,\"publisher\":{\"@id\":\"http:\\\/\\\/www.rcts.fr\\\/#organization\"},\"articleSection\":[\"Haematology\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"http:\\\/\\\/www.rcts.fr\\\/en\\\/utilisation-quotidienne-du-facteur-vii-active-recombinant-dans-les-saignements-aigus-de-lhemophile-acquise-a-resultats-dacqui-7-une-etude-francaise-prospective\\\/\",\"url\":\"http:\\\/\\\/www.rcts.fr\\\/en\\\/utilisation-quotidienne-du-facteur-vii-active-recombinant-dans-les-saignements-aigus-de-lhemophile-acquise-a-resultats-dacqui-7-une-etude-francaise-prospective\\\/\",\"name\":\"Utilisation quotidienne du facteur VII activ\u00e9 recombinant dans les saignements aigus de l\u2019h\u00e9mophile acquise A : r\u00e9sultats d\u2019ACQUI-7, une \u00e9tude fran\u00e7aise prospective - RCTs\",\"isPartOf\":{\"@id\":\"http:\\\/\\\/www.rcts.fr\\\/#website\"},\"datePublished\":\"2020-02-07T17:12:15+00:00\",\"dateModified\":\"2020-04-07T13:58:09+00:00\",\"breadcrumb\":{\"@id\":\"http:\\\/\\\/www.rcts.fr\\\/en\\\/utilisation-quotidienne-du-facteur-vii-active-recombinant-dans-les-saignements-aigus-de-lhemophile-acquise-a-resultats-dacqui-7-une-etude-francaise-prospective\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"http:\\\/\\\/www.rcts.fr\\\/en\\\/utilisation-quotidienne-du-facteur-vii-active-recombinant-dans-les-saignements-aigus-de-lhemophile-acquise-a-resultats-dacqui-7-une-etude-francaise-prospective\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"http:\\\/\\\/www.rcts.fr\\\/en\\\/utilisation-quotidienne-du-facteur-vii-active-recombinant-dans-les-saignements-aigus-de-lhemophile-acquise-a-resultats-dacqui-7-une-etude-francaise-prospective\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"http:\\\/\\\/www.rcts.fr\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Utilisation quotidienne du facteur VII activ\u00e9 recombinant dans les saignements aigus de l\u2019h\u00e9mophile acquise A : r\u00e9sultats d\u2019ACQUI-7, une \u00e9tude fran\u00e7aise prospective\"}]},{\"@type\":\"WebSite\",\"@id\":\"http:\\\/\\\/www.rcts.fr\\\/#website\",\"url\":\"http:\\\/\\\/www.rcts.fr\\\/\",\"name\":\"RCTs\",\"description\":\"Description\",\"publisher\":{\"@id\":\"http:\\\/\\\/www.rcts.fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"http:\\\/\\\/www.rcts.fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"http:\\\/\\\/www.rcts.fr\\\/#organization\",\"name\":\"RCTs\",\"url\":\"http:\\\/\\\/www.rcts.fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"http:\\\/\\\/www.rcts.fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.rcts.fr\\\/wp-content\\\/uploads\\\/logo-blue.svg\",\"contentUrl\":\"https:\\\/\\\/www.rcts.fr\\\/wp-content\\\/uploads\\\/logo-blue.svg\",\"width\":163,\"height\":47,\"caption\":\"RCTs\"},\"image\":{\"@id\":\"http:\\\/\\\/www.rcts.fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"http:\\\/\\\/www.rcts.fr\\\/#\\\/schema\\\/person\\\/19ff6b0ca72b83f30ac0a23e6ce05dc5\",\"name\":\"Didier Not\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/384084503863c2fae1497cd4aff02d7d7ec7ec0d357eb358655b55a5dd586850?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/384084503863c2fae1497cd4aff02d7d7ec7ec0d357eb358655b55a5dd586850?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/384084503863c2fae1497cd4aff02d7d7ec7ec0d357eb358655b55a5dd586850?s=96&d=mm&r=g\",\"caption\":\"Didier Not\"},\"url\":\"https:\\\/\\\/www.rcts.fr\\\/en\\\/author\\\/dnorcts-fr\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Utilisation quotidienne du facteur VII activ\u00e9 recombinant dans les saignements aigus de l\u2019h\u00e9mophile acquise A : r\u00e9sultats d\u2019ACQUI-7, une \u00e9tude fran\u00e7aise prospective - RCTs","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"http:\/\/www.rcts.fr\/en\/utilisation-quotidienne-du-facteur-vii-active-recombinant-dans-les-saignements-aigus-de-lhemophile-acquise-a-resultats-dacqui-7-une-etude-francaise-prospective\/","og_locale":"en_US","og_type":"article","og_title":"Utilisation quotidienne du facteur VII activ\u00e9 recombinant dans les saignements aigus de l\u2019h\u00e9mophile acquise A : r\u00e9sultats d\u2019ACQUI-7, une \u00e9tude fran\u00e7aise prospective - RCTs","og_description":"L\u2019efficacit\u00e9 et la tol\u00e9rance du facteur VII activ\u00e9 recombinant (rFVIIa) sont reconnues chez les patients avec une h\u00e9mophilie A acquise (HAA), mais des donn\u00e9es d\u00e9taill\u00e9es sur le contr\u00f4le du saignement en pratique m\u00e9dicale sont limit\u00e9es. L\u2019objectif de cette \u00e9tude prospective, observationnelle, multicentrique, fran\u00e7aise (ACQUI-7) \u00e9tait de renforcer les connaissances sur les diff\u00e9rents types de saignements [&hellip;]","og_url":"http:\/\/www.rcts.fr\/en\/utilisation-quotidienne-du-facteur-vii-active-recombinant-dans-les-saignements-aigus-de-lhemophile-acquise-a-resultats-dacqui-7-une-etude-francaise-prospective\/","og_site_name":"RCTs","article_published_time":"2020-02-07T17:12:15+00:00","article_modified_time":"2020-04-07T13:58:09+00:00","author":"Didier Not","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Didier Not","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"http:\/\/www.rcts.fr\/en\/utilisation-quotidienne-du-facteur-vii-active-recombinant-dans-les-saignements-aigus-de-lhemophile-acquise-a-resultats-dacqui-7-une-etude-francaise-prospective\/#article","isPartOf":{"@id":"http:\/\/www.rcts.fr\/en\/utilisation-quotidienne-du-facteur-vii-active-recombinant-dans-les-saignements-aigus-de-lhemophile-acquise-a-resultats-dacqui-7-une-etude-francaise-prospective\/"},"author":{"name":"Didier Not","@id":"http:\/\/www.rcts.fr\/#\/schema\/person\/19ff6b0ca72b83f30ac0a23e6ce05dc5"},"headline":"Utilisation quotidienne du facteur VII activ\u00e9 recombinant dans les saignements aigus de l\u2019h\u00e9mophile acquise A : r\u00e9sultats d\u2019ACQUI-7, une \u00e9tude fran\u00e7aise prospective","datePublished":"2020-02-07T17:12:15+00:00","dateModified":"2020-04-07T13:58:09+00:00","mainEntityOfPage":{"@id":"http:\/\/www.rcts.fr\/en\/utilisation-quotidienne-du-facteur-vii-active-recombinant-dans-les-saignements-aigus-de-lhemophile-acquise-a-resultats-dacqui-7-une-etude-francaise-prospective\/"},"wordCount":196,"commentCount":0,"publisher":{"@id":"http:\/\/www.rcts.fr\/#organization"},"articleSection":["Haematology"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"http:\/\/www.rcts.fr\/en\/utilisation-quotidienne-du-facteur-vii-active-recombinant-dans-les-saignements-aigus-de-lhemophile-acquise-a-resultats-dacqui-7-une-etude-francaise-prospective\/","url":"http:\/\/www.rcts.fr\/en\/utilisation-quotidienne-du-facteur-vii-active-recombinant-dans-les-saignements-aigus-de-lhemophile-acquise-a-resultats-dacqui-7-une-etude-francaise-prospective\/","name":"Utilisation quotidienne du facteur VII activ\u00e9 recombinant dans les saignements aigus de l\u2019h\u00e9mophile acquise A : r\u00e9sultats d\u2019ACQUI-7, une \u00e9tude fran\u00e7aise prospective - RCTs","isPartOf":{"@id":"http:\/\/www.rcts.fr\/#website"},"datePublished":"2020-02-07T17:12:15+00:00","dateModified":"2020-04-07T13:58:09+00:00","breadcrumb":{"@id":"http:\/\/www.rcts.fr\/en\/utilisation-quotidienne-du-facteur-vii-active-recombinant-dans-les-saignements-aigus-de-lhemophile-acquise-a-resultats-dacqui-7-une-etude-francaise-prospective\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["http:\/\/www.rcts.fr\/en\/utilisation-quotidienne-du-facteur-vii-active-recombinant-dans-les-saignements-aigus-de-lhemophile-acquise-a-resultats-dacqui-7-une-etude-francaise-prospective\/"]}]},{"@type":"BreadcrumbList","@id":"http:\/\/www.rcts.fr\/en\/utilisation-quotidienne-du-facteur-vii-active-recombinant-dans-les-saignements-aigus-de-lhemophile-acquise-a-resultats-dacqui-7-une-etude-francaise-prospective\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"http:\/\/www.rcts.fr\/en\/"},{"@type":"ListItem","position":2,"name":"Utilisation quotidienne du facteur VII activ\u00e9 recombinant dans les saignements aigus de l\u2019h\u00e9mophile acquise A : r\u00e9sultats d\u2019ACQUI-7, une \u00e9tude fran\u00e7aise prospective"}]},{"@type":"WebSite","@id":"http:\/\/www.rcts.fr\/#website","url":"http:\/\/www.rcts.fr\/","name":"RCTs","description":"Description","publisher":{"@id":"http:\/\/www.rcts.fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"http:\/\/www.rcts.fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"http:\/\/www.rcts.fr\/#organization","name":"RCTs","url":"http:\/\/www.rcts.fr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"http:\/\/www.rcts.fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.rcts.fr\/wp-content\/uploads\/logo-blue.svg","contentUrl":"https:\/\/www.rcts.fr\/wp-content\/uploads\/logo-blue.svg","width":163,"height":47,"caption":"RCTs"},"image":{"@id":"http:\/\/www.rcts.fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"http:\/\/www.rcts.fr\/#\/schema\/person\/19ff6b0ca72b83f30ac0a23e6ce05dc5","name":"Didier Not","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/384084503863c2fae1497cd4aff02d7d7ec7ec0d357eb358655b55a5dd586850?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/384084503863c2fae1497cd4aff02d7d7ec7ec0d357eb358655b55a5dd586850?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/384084503863c2fae1497cd4aff02d7d7ec7ec0d357eb358655b55a5dd586850?s=96&d=mm&r=g","caption":"Didier Not"},"url":"https:\/\/www.rcts.fr\/en\/author\/dnorcts-fr\/"}]}},"_links":{"self":[{"href":"https:\/\/www.rcts.fr\/en\/wp-json\/wp\/v2\/posts\/2646","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.rcts.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.rcts.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.rcts.fr\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.rcts.fr\/en\/wp-json\/wp\/v2\/comments?post=2646"}],"version-history":[{"count":1,"href":"https:\/\/www.rcts.fr\/en\/wp-json\/wp\/v2\/posts\/2646\/revisions"}],"predecessor-version":[{"id":2647,"href":"https:\/\/www.rcts.fr\/en\/wp-json\/wp\/v2\/posts\/2646\/revisions\/2647"}],"wp:attachment":[{"href":"https:\/\/www.rcts.fr\/en\/wp-json\/wp\/v2\/media?parent=2646"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.rcts.fr\/en\/wp-json\/wp\/v2\/categories?post=2646"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}